Skip to main content
Big Ideas 2024 Is Here! Download Now
Subscribe
Subscribe

Search Results For

Result: NaN items

Articles

Found: 30 items

Oct. 30, 2014 by James Bannon
analyst research

Sequencing the Ebola Virus on the Front Line in Africa

Tags DNA Sequencing, Health, Instrumentation
Mar. 13, 2019 by Simon Barnett
analyst research

Liquid Biopsies to Detect Cancer Could Boost Annual Sequencing Volume By 40-Fold

Tags Cancer Treatment, Genomics, Health
Aug. 30, 2021 by Simon Barnett
analyst research

The Exploitable Genomics of Cancer: Earlier Cancer Detection Part II

Tags Cancer, Genomics, Liquid Biopsy, Oncology

White papers

Found: 2 items

May. 30, 2019 by Brett Winton
Published: May. 30, 2019

Disruptive Innovation: Why Now?

Nov. 15, 2016 by Catherine Wood

Videos

Found: 4 items

Tue, Mar 10, 2020

Not Your Traditional Investment Firm

ARK is an investment manager focused solely on disruptive innovation. Rooted in over 40 years of experience, we aim to identify large-scale investment opportunities in the public markets resulting from technological innovations centered around DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain technology. Learn why we believe innovation is key to growth and what sets us apart from other investment firms.

Sat, Mar 05, 2022

BIS2022 - Gene Editing: Curing Disease, Not Masking Symptoms

The convergence of next generation DNA sequencing, CRISPR gene-editing, and artificial intelligence (AI) has the potential to transform health care. These advances could accelerate the pace of scientific discovery, personalizing medicine to cure disease instead of masking symptoms.

You are leaving ark-invest.com
By clicking below you acknowledge that you are navigating away from ark-invest.com and will be connected to ark-funds.com ARK Investment Management LLC manages both web domains. Please take note of ARK’s privacy policy, terms of use, and disclosures that may vary between sites.